Internal Medicine, Gastroenterology · Little Rock, AR
NPI
1528003977
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10915 N Rodney Parham Rd
Little Rock, AR, 72212
Phone (501) 747-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$437K
12,506 services
Medicare patients, 2024
755
Average age 73
Drug cost, 2024
$1.7M
4,664 prescriptions
Company payments, 2025
$2,360
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Angelo G Coppola Jr. was code 99439 (chronic, principal, and transitional care management), 2,556 times for 204 patients. In total Angelo G Coppola Jr. billed 12,506 services in 49 codes, and Medicare paid $437K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-22.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99439 Chronic, Principal, and Transitional Care Management | Office | 2,556 | 204 | $33.75 | $86K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 1,443 | 205 | $44.12 | $64K |
| 88305 Surgical Pathology Examination | Office | 624 | 295 | $23.31 | $15K |
| 99214 Office E&M - Established | Office | 502 | 362 | $82.10 | $41K |
| 88313 Surgical Pathology Examination | Office | 409 | 218 | $47.20 | $19K |
| 88312 Surgical Pathology Examination | Office | 255 | 207 | $57.50 | $15K |
| 43239 Upper GI Endoscopy | Facility | 241 | 224 | $56.27 | $14K |
| 99457 E&M - Miscellaneous | Office | 214 | 33 | $34.26 | $7,331 |
| 99454 E&M - Miscellaneous | Office | 200 | 32 | $30.95 | $6,189 |
| 99213 Office E&M - Established | Office | 170 | 158 | $56.05 | $9,528 |
| 45385 Colonoscopy - Lesion Removal | Facility | 87 | 86 | $174.73 | $15K |
| 99204 Office E&M - New | Office | 79 | 79 | $109.83 | $8,677 |
| 43249 Upper GI Endoscopy | Facility | 76 | 67 | $96.39 | $7,325 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 67 | 67 | $159.70 | $11K |
| 45380 Lower GI Endoscopy - Other | Facility | 45 | 45 | $125.25 | $5,636 |
By year: 2022 $354K for 9,299 services; 2023 $325K for 8,359 services; 2024 $437K for 12,506 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 624 | 295 | $23.31 | $15K |
| 88313 Surgical Pathology Examination | 409 | 218 | $47.20 | $19K |
| 88312 Surgical Pathology Examination | 255 | 207 | $57.50 | $15K |
Medicare prescription drug claims, 2024
In 2024, the drug Angelo G Coppola Jr. prescribed most often to Medicare patients was Pantoprazole Sodium, with 1,359 prescriptions and refills. In total Angelo G Coppola Jr. wrote 4,664 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Pantoprazole Sodium Generic | 1,359 | 3,509 | 500 | $25K |
| Dicyclomine Hcl Generic | 601 | 793 | 171 | $14K |
| Famotidine Generic | 283 | 528 | 69 | $4,431 |
| Metoclopramide Hcl Generic | 257 | 321 | 75 | $2,190 |
| Omeprazole Generic | 184 | 468 | 71 | $4,584 |
| Linzess Linaclotide | 168 | 288 | 50 | $152K |
| Sucralfate Generic | 162 | 182 | 49 | $17K |
| Colesevelam Hcl Generic | 152 | 167 | 48 | $11K |
| Ondansetron Odt Ondansetron | 141 | 149 | 54 | $3,002 |
| Esomeprazole Magnesium Generic | 99 | 193 | 31 | $5,574 |
| Promethazine Hcl Generic | 97 | 97 | 27 | $834 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 91 | 131 | 37 | $1,535 |
| Colestipol Hcl Generic | 85 | 141 | 22 | $5,646 |
| Ursodiol Generic | 79 | 110 | 14 | $16K |
| Dexlansoprazole Dr Dexlansoprazole | 51 | 98 | 14 | $22K |
Brand drugs: - claims; generic drugs: 4,059 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Angelo G Coppola Jr. $2,360 ($2,360 in general payments such as food, travel and fees) from 19 companies. The largest payer was Abbvie Inc. with $655.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 66 | $655 |
| Medtronic, Inc. MDT | 10 | $467 |
| Janssen Biotech, Inc. JNJ | 17 | $347 |
| Gilead Sciences, Inc. GILD | 12 | $216 |
| Regeneron Healthcare Solutions, Inc. REGN | 10 | $187 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 14 | $153 |
| Lilly USA, LLC LLY | 4 | $70.59 |
| Phathom Pharmaceuticals, Inc. PHAT | 5 | $50.32 |
| Genzyme Corporation SNY | 2 | $46.27 |
| Amgen Inc. AMGN | 2 | $35.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.